Optic neuritis, multiple sclerosis and human leukocyte antigen: results of a 4-year follow-up study

In the present study the relation between human leukocyte antigen (HLA), optic neuritis (ON) and multiple sclerosis (MS) has been investigated in 56 Iranian patients (46 females and 10 males). HLA‐A and ‐B typing by microlymphocytotoxicity method and HLA‐DRB, DQA and DQB by polymerase chain reaction...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:European journal of neurology 2005-01, Vol.12 (1), p.25-30
Hauptverfasser: Amirzargar, A. A., Tabasi, A., Khosravi, F., Kheradvar, A., Rezaei, N., Naroueynejad, M., Ansaripour, B., Moradi, B., Nikbin, B.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 30
container_issue 1
container_start_page 25
container_title European journal of neurology
container_volume 12
creator Amirzargar, A. A.
Tabasi, A.
Khosravi, F.
Kheradvar, A.
Rezaei, N.
Naroueynejad, M.
Ansaripour, B.
Moradi, B.
Nikbin, B.
description In the present study the relation between human leukocyte antigen (HLA), optic neuritis (ON) and multiple sclerosis (MS) has been investigated in 56 Iranian patients (46 females and 10 males). HLA‐A and ‐B typing by microlymphocytotoxicity method and HLA‐DRB, DQA and DQB by polymerase chain reaction based on sequence specific primers method was performed for the selected patients with ON. The diagnosis of clinically defined MS (CDMS) was confirmed in 15 of them (26.7%) during their follow‐up. HLA‐A24 was significantly higher in ON patients, whilst A23, A26, and A30 showed a significant decrease in these patients. HLA‐A10 and A26 were absent in CDMS patients and A2 and A11 were significantly decreased in ON and CDMS patients. HLA‐B5, B51, B38, B27, and B35 were significantly increased in ON patients compared with control subjects. HLA‐B44, B16 and B38 alleles were not present in CDMS patients. Regarding DR locus, the frequency of HLA‐DRB1*15 and DRB1*04 has been increased in CDMS patients, whilst the frequency of HLA‐DRB1*07 and *11 was much higher in ON patients. In DQA region, the most frequent allele in the MS patients was DQA1*0102, which was significantly higher than ON patients, and control group. The frequency of DQA1*0103 was significantly increased in both patients group. In DQB1, the frequency of DQB1*0602 increased significantly in the MS patients. In conclusion existence of common genetic basis for early manifestations of MS could be suggested.
doi_str_mv 10.1111/j.1468-1331.2004.00901.x
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_67333459</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>67333459</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4041-f244735f0ce93235c3531c6e171bc00fd8b93ae4831fd0123d0d659e6ec23d953</originalsourceid><addsrcrecordid>eNqNkE1v1DAQhiNERUvLX0A-cSKpJ2PnA3FB7bJUqloJ0cLNyjoT8Nb5qJ2om3-P012VK754ZL_PjP1EEQOeQFjn2wREVsSACEnKuUg4Lzkku1fRycvF61CjhFgCh-Porfdbznmap_xNdAwyAwSBJ5G-HUajWUeTM6PxH1k72dEMlpjXllzvjWdVV7M_U1t1zNL00Ot5pHA2mt_UfWKOfCA86xtWMRHPVDnW9Nb2T_E0MD9O9XwWHTWV9fTusJ9Gd19XPy6-xde366uLL9exFlxA3KRC5CgbrqnEFKVGiaAzghw2mvOmLjYlViQKhKbmkGLN60yWlJEOdSnxNPqw7zu4_nEiP6rWeE3WVh31k1dZjohCliFY7IM6fNA7atTgTFu5WQFXi2C1VYtHtXhUi2D1LFjtAvr-MGPatFT_Aw9GQ-DzPvBkLM3_3VitblahCHi8x40fafeCV-5heX4u1c-btbr8fo-_isu1use_TSiYeg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>67333459</pqid></control><display><type>article</type><title>Optic neuritis, multiple sclerosis and human leukocyte antigen: results of a 4-year follow-up study</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Amirzargar, A. A. ; Tabasi, A. ; Khosravi, F. ; Kheradvar, A. ; Rezaei, N. ; Naroueynejad, M. ; Ansaripour, B. ; Moradi, B. ; Nikbin, B.</creator><creatorcontrib>Amirzargar, A. A. ; Tabasi, A. ; Khosravi, F. ; Kheradvar, A. ; Rezaei, N. ; Naroueynejad, M. ; Ansaripour, B. ; Moradi, B. ; Nikbin, B.</creatorcontrib><description>In the present study the relation between human leukocyte antigen (HLA), optic neuritis (ON) and multiple sclerosis (MS) has been investigated in 56 Iranian patients (46 females and 10 males). HLA‐A and ‐B typing by microlymphocytotoxicity method and HLA‐DRB, DQA and DQB by polymerase chain reaction based on sequence specific primers method was performed for the selected patients with ON. The diagnosis of clinically defined MS (CDMS) was confirmed in 15 of them (26.7%) during their follow‐up. HLA‐A24 was significantly higher in ON patients, whilst A23, A26, and A30 showed a significant decrease in these patients. HLA‐A10 and A26 were absent in CDMS patients and A2 and A11 were significantly decreased in ON and CDMS patients. HLA‐B5, B51, B38, B27, and B35 were significantly increased in ON patients compared with control subjects. HLA‐B44, B16 and B38 alleles were not present in CDMS patients. Regarding DR locus, the frequency of HLA‐DRB1*15 and DRB1*04 has been increased in CDMS patients, whilst the frequency of HLA‐DRB1*07 and *11 was much higher in ON patients. In DQA region, the most frequent allele in the MS patients was DQA1*0102, which was significantly higher than ON patients, and control group. The frequency of DQA1*0103 was significantly increased in both patients group. In DQB1, the frequency of DQB1*0602 increased significantly in the MS patients. In conclusion existence of common genetic basis for early manifestations of MS could be suggested.</description><identifier>ISSN: 1351-5101</identifier><identifier>EISSN: 1468-1331</identifier><identifier>DOI: 10.1111/j.1468-1331.2004.00901.x</identifier><identifier>PMID: 15613143</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Science Ltd</publisher><subject>Adolescent ; Adult ; Alleles ; Child ; Confidence Intervals ; Female ; Follow-Up Studies ; Histocompatibility Testing - methods ; HLA-A Antigens - genetics ; HLA-B Antigens - genetics ; HLA-DQ alpha-Chains ; HLA-DQ Antigens - genetics ; HLA-DQ beta-Chains ; HLA-DR Antigens - genetics ; HLA-DRB1 Chains ; human leukocyte antigen ; Humans ; Male ; multiple sclerosis ; Multiple Sclerosis - genetics ; Multiple Sclerosis - immunology ; Odds Ratio ; optic neuritis ; Optic Neuritis - genetics ; Optic Neuritis - immunology</subject><ispartof>European journal of neurology, 2005-01, Vol.12 (1), p.25-30</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4041-f244735f0ce93235c3531c6e171bc00fd8b93ae4831fd0123d0d659e6ec23d953</citedby><cites>FETCH-LOGICAL-c4041-f244735f0ce93235c3531c6e171bc00fd8b93ae4831fd0123d0d659e6ec23d953</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fj.1468-1331.2004.00901.x$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fj.1468-1331.2004.00901.x$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27903,27904,45553,45554</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15613143$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Amirzargar, A. A.</creatorcontrib><creatorcontrib>Tabasi, A.</creatorcontrib><creatorcontrib>Khosravi, F.</creatorcontrib><creatorcontrib>Kheradvar, A.</creatorcontrib><creatorcontrib>Rezaei, N.</creatorcontrib><creatorcontrib>Naroueynejad, M.</creatorcontrib><creatorcontrib>Ansaripour, B.</creatorcontrib><creatorcontrib>Moradi, B.</creatorcontrib><creatorcontrib>Nikbin, B.</creatorcontrib><title>Optic neuritis, multiple sclerosis and human leukocyte antigen: results of a 4-year follow-up study</title><title>European journal of neurology</title><addtitle>Eur J Neurol</addtitle><description>In the present study the relation between human leukocyte antigen (HLA), optic neuritis (ON) and multiple sclerosis (MS) has been investigated in 56 Iranian patients (46 females and 10 males). HLA‐A and ‐B typing by microlymphocytotoxicity method and HLA‐DRB, DQA and DQB by polymerase chain reaction based on sequence specific primers method was performed for the selected patients with ON. The diagnosis of clinically defined MS (CDMS) was confirmed in 15 of them (26.7%) during their follow‐up. HLA‐A24 was significantly higher in ON patients, whilst A23, A26, and A30 showed a significant decrease in these patients. HLA‐A10 and A26 were absent in CDMS patients and A2 and A11 were significantly decreased in ON and CDMS patients. HLA‐B5, B51, B38, B27, and B35 were significantly increased in ON patients compared with control subjects. HLA‐B44, B16 and B38 alleles were not present in CDMS patients. Regarding DR locus, the frequency of HLA‐DRB1*15 and DRB1*04 has been increased in CDMS patients, whilst the frequency of HLA‐DRB1*07 and *11 was much higher in ON patients. In DQA region, the most frequent allele in the MS patients was DQA1*0102, which was significantly higher than ON patients, and control group. The frequency of DQA1*0103 was significantly increased in both patients group. In DQB1, the frequency of DQB1*0602 increased significantly in the MS patients. In conclusion existence of common genetic basis for early manifestations of MS could be suggested.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Alleles</subject><subject>Child</subject><subject>Confidence Intervals</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>Histocompatibility Testing - methods</subject><subject>HLA-A Antigens - genetics</subject><subject>HLA-B Antigens - genetics</subject><subject>HLA-DQ alpha-Chains</subject><subject>HLA-DQ Antigens - genetics</subject><subject>HLA-DQ beta-Chains</subject><subject>HLA-DR Antigens - genetics</subject><subject>HLA-DRB1 Chains</subject><subject>human leukocyte antigen</subject><subject>Humans</subject><subject>Male</subject><subject>multiple sclerosis</subject><subject>Multiple Sclerosis - genetics</subject><subject>Multiple Sclerosis - immunology</subject><subject>Odds Ratio</subject><subject>optic neuritis</subject><subject>Optic Neuritis - genetics</subject><subject>Optic Neuritis - immunology</subject><issn>1351-5101</issn><issn>1468-1331</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkE1v1DAQhiNERUvLX0A-cSKpJ2PnA3FB7bJUqloJ0cLNyjoT8Nb5qJ2om3-P012VK754ZL_PjP1EEQOeQFjn2wREVsSACEnKuUg4Lzkku1fRycvF61CjhFgCh-Porfdbznmap_xNdAwyAwSBJ5G-HUajWUeTM6PxH1k72dEMlpjXllzvjWdVV7M_U1t1zNL00Ot5pHA2mt_UfWKOfCA86xtWMRHPVDnW9Nb2T_E0MD9O9XwWHTWV9fTusJ9Gd19XPy6-xde366uLL9exFlxA3KRC5CgbrqnEFKVGiaAzghw2mvOmLjYlViQKhKbmkGLN60yWlJEOdSnxNPqw7zu4_nEiP6rWeE3WVh31k1dZjohCliFY7IM6fNA7atTgTFu5WQFXi2C1VYtHtXhUi2D1LFjtAvr-MGPatFT_Aw9GQ-DzPvBkLM3_3VitblahCHi8x40fafeCV-5heX4u1c-btbr8fo-_isu1use_TSiYeg</recordid><startdate>200501</startdate><enddate>200501</enddate><creator>Amirzargar, A. A.</creator><creator>Tabasi, A.</creator><creator>Khosravi, F.</creator><creator>Kheradvar, A.</creator><creator>Rezaei, N.</creator><creator>Naroueynejad, M.</creator><creator>Ansaripour, B.</creator><creator>Moradi, B.</creator><creator>Nikbin, B.</creator><general>Blackwell Science Ltd</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>200501</creationdate><title>Optic neuritis, multiple sclerosis and human leukocyte antigen: results of a 4-year follow-up study</title><author>Amirzargar, A. A. ; Tabasi, A. ; Khosravi, F. ; Kheradvar, A. ; Rezaei, N. ; Naroueynejad, M. ; Ansaripour, B. ; Moradi, B. ; Nikbin, B.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4041-f244735f0ce93235c3531c6e171bc00fd8b93ae4831fd0123d0d659e6ec23d953</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Alleles</topic><topic>Child</topic><topic>Confidence Intervals</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>Histocompatibility Testing - methods</topic><topic>HLA-A Antigens - genetics</topic><topic>HLA-B Antigens - genetics</topic><topic>HLA-DQ alpha-Chains</topic><topic>HLA-DQ Antigens - genetics</topic><topic>HLA-DQ beta-Chains</topic><topic>HLA-DR Antigens - genetics</topic><topic>HLA-DRB1 Chains</topic><topic>human leukocyte antigen</topic><topic>Humans</topic><topic>Male</topic><topic>multiple sclerosis</topic><topic>Multiple Sclerosis - genetics</topic><topic>Multiple Sclerosis - immunology</topic><topic>Odds Ratio</topic><topic>optic neuritis</topic><topic>Optic Neuritis - genetics</topic><topic>Optic Neuritis - immunology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Amirzargar, A. A.</creatorcontrib><creatorcontrib>Tabasi, A.</creatorcontrib><creatorcontrib>Khosravi, F.</creatorcontrib><creatorcontrib>Kheradvar, A.</creatorcontrib><creatorcontrib>Rezaei, N.</creatorcontrib><creatorcontrib>Naroueynejad, M.</creatorcontrib><creatorcontrib>Ansaripour, B.</creatorcontrib><creatorcontrib>Moradi, B.</creatorcontrib><creatorcontrib>Nikbin, B.</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of neurology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Amirzargar, A. A.</au><au>Tabasi, A.</au><au>Khosravi, F.</au><au>Kheradvar, A.</au><au>Rezaei, N.</au><au>Naroueynejad, M.</au><au>Ansaripour, B.</au><au>Moradi, B.</au><au>Nikbin, B.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Optic neuritis, multiple sclerosis and human leukocyte antigen: results of a 4-year follow-up study</atitle><jtitle>European journal of neurology</jtitle><addtitle>Eur J Neurol</addtitle><date>2005-01</date><risdate>2005</risdate><volume>12</volume><issue>1</issue><spage>25</spage><epage>30</epage><pages>25-30</pages><issn>1351-5101</issn><eissn>1468-1331</eissn><abstract>In the present study the relation between human leukocyte antigen (HLA), optic neuritis (ON) and multiple sclerosis (MS) has been investigated in 56 Iranian patients (46 females and 10 males). HLA‐A and ‐B typing by microlymphocytotoxicity method and HLA‐DRB, DQA and DQB by polymerase chain reaction based on sequence specific primers method was performed for the selected patients with ON. The diagnosis of clinically defined MS (CDMS) was confirmed in 15 of them (26.7%) during their follow‐up. HLA‐A24 was significantly higher in ON patients, whilst A23, A26, and A30 showed a significant decrease in these patients. HLA‐A10 and A26 were absent in CDMS patients and A2 and A11 were significantly decreased in ON and CDMS patients. HLA‐B5, B51, B38, B27, and B35 were significantly increased in ON patients compared with control subjects. HLA‐B44, B16 and B38 alleles were not present in CDMS patients. Regarding DR locus, the frequency of HLA‐DRB1*15 and DRB1*04 has been increased in CDMS patients, whilst the frequency of HLA‐DRB1*07 and *11 was much higher in ON patients. In DQA region, the most frequent allele in the MS patients was DQA1*0102, which was significantly higher than ON patients, and control group. The frequency of DQA1*0103 was significantly increased in both patients group. In DQB1, the frequency of DQB1*0602 increased significantly in the MS patients. In conclusion existence of common genetic basis for early manifestations of MS could be suggested.</abstract><cop>Oxford, UK</cop><pub>Blackwell Science Ltd</pub><pmid>15613143</pmid><doi>10.1111/j.1468-1331.2004.00901.x</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1351-5101
ispartof European journal of neurology, 2005-01, Vol.12 (1), p.25-30
issn 1351-5101
1468-1331
language eng
recordid cdi_proquest_miscellaneous_67333459
source MEDLINE; Wiley Online Library Journals Frontfile Complete
subjects Adolescent
Adult
Alleles
Child
Confidence Intervals
Female
Follow-Up Studies
Histocompatibility Testing - methods
HLA-A Antigens - genetics
HLA-B Antigens - genetics
HLA-DQ alpha-Chains
HLA-DQ Antigens - genetics
HLA-DQ beta-Chains
HLA-DR Antigens - genetics
HLA-DRB1 Chains
human leukocyte antigen
Humans
Male
multiple sclerosis
Multiple Sclerosis - genetics
Multiple Sclerosis - immunology
Odds Ratio
optic neuritis
Optic Neuritis - genetics
Optic Neuritis - immunology
title Optic neuritis, multiple sclerosis and human leukocyte antigen: results of a 4-year follow-up study
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T02%3A10%3A49IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Optic%20neuritis,%20multiple%20sclerosis%20and%20human%20leukocyte%20antigen:%20results%20of%20a%204-year%20follow-up%20study&rft.jtitle=European%20journal%20of%20neurology&rft.au=Amirzargar,%20A.%20A.&rft.date=2005-01&rft.volume=12&rft.issue=1&rft.spage=25&rft.epage=30&rft.pages=25-30&rft.issn=1351-5101&rft.eissn=1468-1331&rft_id=info:doi/10.1111/j.1468-1331.2004.00901.x&rft_dat=%3Cproquest_cross%3E67333459%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=67333459&rft_id=info:pmid/15613143&rfr_iscdi=true